VREO.CN
Vireo Health International Inc
Price:  
14.84 
CAD
Volume:  
4,380.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VREO.CN WACC - Weighted Average Cost of Capital

The WACC of Vireo Health International Inc (VREO.CN) is 9.8%.

The Cost of Equity of Vireo Health International Inc (VREO.CN) is 6.35%.
The Cost of Debt of Vireo Health International Inc (VREO.CN) is 22.40%.

Range Selected
Cost of equity 5.40% - 7.30% 6.35%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 20.20% - 24.60% 22.40%
WACC 8.6% - 11.0% 9.8%
WACC

VREO.CN WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.44 0.52
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.40% 7.30%
Tax rate 25.90% 26.50%
Debt/Equity ratio 0.52 0.52
Cost of debt 20.20% 24.60%
After-tax WACC 8.6% 11.0%
Selected WACC 9.8%

VREO.CN's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for VREO.CN:

cost_of_equity (6.35%) = risk_free_rate (3.45%) + equity_risk_premium (5.60%) * adjusted_beta (0.44) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.